欧美mv日韩mv国产-国产午夜一级片-一区二区在线 | 国-韩国无码一区二区三区免费视频-黄色a免费-欧美黄色大片免费观看-人人综合网-国产成人a在线观看视频免费-国内精品久久久久久久影视-国产老头和老太xxxx视频-高h放荡受浪受bl-国产又爽又黄又不遮挡视频-国产偷国产偷亚洲高清人乐享

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > pLDLR3 [pLDLR-3]
最近瀏覽歷史
聯系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮海區莊市街道興莊路9號
  • 創e慧谷42號樓B幢401室
pLDLR3 [pLDLR-3]
pLDLR3 [pLDLR-3]
規格:
貨期:
編號:B230354
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規格:
凍干粉
斜面
甘油
平板


產品名稱 pLDLR3 [pLDLR-3]
商品貨號 B230354
Designations pLDLR3 [pLDLR-3]
Species Homo sapiens, human
Depositors DW Russell
Applications
The BamHI fragment (2355/3466) contains exons 1 - 8 and has been used to detect the TaqI polymorphism.
A 1.7 kb HindIII(2337)/BglII(4903) fragment has been used as a single copy probe.
The AvaII polymorphic site is in exon 3. The non-polymorphic XbaI site is in intron 12 and is used to yield more separable bands.
Vector
Construct size (kb): 7.849999904632568
Insert
DNA: cDNA
Insert lengths(kb): 5.300000190734863
Tissue: fetal adrenal gland
Gene product: low density lipoprotein receptor (familial hypercholesterolemia)(low density lipoprotein receptor) [LDLR]
Alleles: A2, E1, E2, A1, A2, B1, B2, D1, D2, K1, K2, Q1, Q2, S2, A1, S1
Insert Size (kb) 5.300
Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Shipping Information Distributed: freeze-dried
Comments
Restriction digests of the clone give the following sizes (kb): EcoRI--9; HindIII--9; PstI--3.2, 2.1, 1.05, 0.76. 0.32; BamHI--2.6, 2.1, 1.7, 1.15, 0.41.
The vector is pcD minus the SV40 early region promoter.
The BamHI fragment (2355/3466) contains exons 1 - 8 and has been used to detect the TaqI polymorphism.
A 1.7 kb HindIII(2337)/BglII(4903) fragment has been used as a single copy probe.
The insert, which is a full-length copy of the cDNA, is the same as that described for pLDLR-2.
The Alu repeat sequences in the cDNA occur in a 1.7 kb BamHI fragment (5874-7600). A SmaI(5191)/XbaI(2349) or SmaI/SalI(2343) or SmaI/HindIII(2337) double digest should generate a single-copy probe.
Recorded as not polymorphic by Collaborative Research, meaning either not polymorphic in 0.8% agarose gels, or difficult to work with.
The AvaII polymorphic site is in exon 3. The non-polymorphic XbaI site is in intron 12 and is used to yield more separable bands.
The PvuII site polymorphism is part of an Alu repeat in intron 15. The sequence of one allele is CGGCTG, the other is CAGCTG (PvuII site).
ApaLI digest shows 3 alleles: 26.4, 22.4, 19.6 kb. ApaLI/BamHI digest shows 4 alleles. (E) alleles detected by 3' exon 18 probe from pLDLR3 map to 3' flanking region. D and E alleles are in linkage disequilibrium. D2 in not detected in the absence of
Enzyme(s) not detecting polymorphism: BamHI, BglII, EcoRI, EcoRV, HindIII, KpnI, SacI, SstI, SstII, SphI, XbaI, XhoI.
References

Yamamoto T, et al. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39: 27-38, 1984. PubMed: 6091915

Hobbs HH, et al. AvaII polymorphism in the human LDL receptor gene. Nucleic Acids Res. 15: 379, 1987. PubMed: 2881256

Hobbs HH, et al. Polymorphism and evolution of Alu sequences in the human low density lipoprotein receptor gene. Proc. Natl. Acad. Sci. USA 82: 7651-7655, 1985. PubMed: 2999774

Leitersdorf E, Hobbs HH. Human LDL receptor gene: two ApaLI RFLPs. Nucleic Acids Res. 15: 2782, 1987. PubMed: 2882479

Yamakawa K, et al. TaqI polymorphism in the human LDL receptor gene. Nucleic Acids Res. 15: 7659, 1987. PubMed: 2889198

Barbara Weiffenbach, personal communication

梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |